ARCHIVES

US Preventive Services Task Force To Downgrade PSA Screening From “I” to “D” — As In “Don’t Do it.”

This article is from The Cancer Letter archive.

Vol. 37 No. 37 | October 6, 2011

Download PDF Visit The Full Archive

Related Articles

The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken.

May 7, 2004

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

In Brief: Stipends Out For Trainees In new Clinical Program, But They Can Be Paid If Any Money Is Available

May 31, 1974

Obit: J. Gale Katterhagen, NCAB’s First Community Physician.

May 4, 2001

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976